Adaptimmune Therapeutics PLC (ADAP)
1.19
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
1.195
0.00 (0.00%)
After-Hours: 20:00
Adaptimmune Therapeutics Cash from Investing (Quarterly): 68.20M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 68.20M |
| September 30, 2023 | 57.31M |
| June 30, 2023 | 2.694M |
| March 31, 2023 | 48.34M |
| December 31, 2022 | 20.95M |
| September 30, 2022 | 28.85M |
| June 30, 2022 | 44.11M |
| March 31, 2022 | -4.775M |
| December 31, 2021 | -28.49M |
| September 30, 2021 | 34.85M |
| June 30, 2021 | 47.68M |
| March 31, 2021 | 21.76M |
| December 31, 2020 | 7.608M |
| September 30, 2020 | -27.58M |
| June 30, 2020 | -187.00M |
| March 31, 2020 | -71.95M |
| December 31, 2019 | 23.68M |
| September 30, 2019 | 35.04M |
| Date | Value |
|---|---|
| June 30, 2019 | 18.56M |
| March 31, 2019 | 17.66M |
| December 31, 2018 | -52.41M |
| September 30, 2018 | 0.942M |
| June 30, 2018 | 20.37M |
| March 31, 2018 | 13.64M |
| December 31, 2017 | -40.01M |
| September 30, 2017 | 9.751M |
| June 30, 2017 | -73.18M |
| March 31, 2017 | -22.64M |
| December 31, 2016 | 16.96M |
| September 30, 2016 | 5.743M |
| June 30, 2016 | 5.617M |
| March 31, 2016 | -10.56M |
| September 30, 2015 | -9.862M |
| December 31, 2014 | -26.18M |
| September 30, 2014 | -0.5278M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-187.00M
Minimum
Jun 2020
68.20M
Maximum
Dec 2023
7.36M
Average
21.76M
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana PLC | 0.0038M |
| Autolus Therapeutics PLC | -1.477M |
| TC BioPharm (Holdings) PLC | -- |
| Bicycle Therapeutics PLC | -0.051M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -14.68M |
| Cash from Financing (Quarterly) | 0.074M |
| Free Cash Flow | -145.76M |
| Free Cash Flow Per Share (Quarterly) | -0.0682 |
| Free Cash Flow to Equity (Quarterly) | -15.50M |
| Free Cash Flow to Firm (Quarterly) | -15.50M |
| Free Cash Flow Yield | -60.85% |